{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:29:52Z","timestamp":1757611792650,"version":"3.44.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","sleep.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine Clinics"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jsmc.2025.05.002","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T07:16:05Z","timestamp":1749453365000},"page":"259-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Biofluid Biomarkers of Sleep Dysfunction in Parkinson\u2019s Disease"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6073-3578","authenticated-orcid":false,"given":"Ruy","family":"G\u00f3mez-Oc\u00e1diz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-3802","authenticated-orcid":false,"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jsmc.2025.05.002_bib1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson\u2019s disease","volume":"391","author":"Tanner","year":"2024","journal-title":"N Engl J Med"},{"issue":"10291","key":"10.1016\/j.jsmc.2025.05.002_bib2","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jsmc.2025.05.002_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jsmc.2025.05.002_bib4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the global burden of disease study 2016","volume":"17","year":"2018","journal-title":"Lancet Neurol"},{"year":"2021","series-title":"Principles and practice of movement disorders","author":"Jankovic","key":"10.1016\/j.jsmc.2025.05.002_bib5"},{"issue":"9","key":"10.1016\/j.jsmc.2025.05.002_bib6","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1474-4422(24)00170-4","article-title":"Sleep and sleep disorders in people with Parkinson\u2019s disease","volume":"23","author":"Iranzo","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jsmc.2025.05.002_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/bs.pbr.2020.01.003","article-title":"Prodromal PD: a new nosological entity","volume":"252","author":"Schaeffer","year":"2020","journal-title":"Prog Brain Res"},{"issue":"3","key":"10.1016\/j.jsmc.2025.05.002_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11064-014-1488-7","article-title":"Are sleep disturbances preclinical markers of Parkinson\u2019s disease?","volume":"40","author":"dos Santos","year":"2015","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jsmc.2025.05.002_bib9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/bs.irn.2023.08.008","article-title":"Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson\u2019s disease","volume":"174","author":"Lima","year":"2024","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"10.1016\/j.jsmc.2025.05.002_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.jsmc.2025.05.002_bib11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00702-018-1910-4","article-title":"Diagnostic biomarkers for Parkinson\u2019s disease at a glance: where are we?","volume":"125","author":"Cova","year":"2018","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.jsmc.2025.05.002_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.smrv.2018.09.008","article-title":"The risk of neurodegeneration in REM sleep behavior disorder: a systematic review and meta-analysis of longitudinal studies","volume":"43","author":"Galbiati","year":"2019","journal-title":"Sleep Med Rev"},{"issue":"6","key":"10.1016\/j.jsmc.2025.05.002_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes - key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.jsmc.2025.05.002_bib14","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.jsmc.2025.05.002_bib15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/acn3.52089","article-title":"Sleep disturbances, cognitive decline, and AD biomarkers alterations in early Parkinson\u2019s disease","volume":"11","author":"Zhong","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.002_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mds.27670","article-title":"Prodromal parkinson\u2019s disease: the decade past, the decade to come","volume":"34","author":"Postuma","year":"2019","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.jsmc.2025.05.002_bib17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","article-title":"Advances in markers of prodromal Parkinson disease","volume":"12","author":"Postuma","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.jsmc.2025.05.002_bib18","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1093\/brain\/awad072","article-title":"Progression of clinical markers in prodromal Parkinson\u2019s disease and dementia with lewy bodies: a multicentre study","volume":"146","author":"Joza","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.jsmc.2025.05.002_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.parkreldis.2022.08.011","article-title":"Idiopathic rapid eye movement sleep behavior disorder in Japan: an observational study","volume":"103","author":"Nishikawa","year":"2022","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.14336\/AD.2023.0518","article-title":"Relationships between rapid eye movement sleep behavior disorder and parkinson\u2019s disease: indication from gut microbiota alterations","volume":"15","author":"Zhang","year":"2024","journal-title":"Aging Dis"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41598-017-00047-5","article-title":"Automated analysis of connected speech reveals early biomarkers of Parkinson\u2019s disease in patients with rapid eye movement sleep behaviour disorder","volume":"7","author":"Hlavni\u010dka","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ana.26085","article-title":"Speech biomarkers in rapid eye movement sleep behavior disorder and parkinson disease","volume":"90","author":"Rusz","year":"2021","journal-title":"Ann Neurol"},{"issue":"10","key":"10.1016\/j.jsmc.2025.05.002_bib23","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1002\/mds.29921","article-title":"Smartphone voice calls provide early biomarkers of parkinsonism in rapid eye movement sleep behavior disorder","volume":"39","author":"Illner","year":"2024","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.jsmc.2025.05.002_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/acn3.50982","article-title":"Rhythm disturbances as a potential early marker of Parkinson\u2019s disease in idiopathic REM sleep behavior disorder","volume":"7","author":"Cochen De Cock","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jsmc.2025.05.002_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.sleep.2020.07.019","article-title":"Instrumental analysis of finger tapping reveals a novel early biomarker of parkinsonism in idiopathic rapid eye movement sleep behaviour disorder","volume":"75","author":"Krupi\u010dka","year":"2020","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.002_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.13589","article-title":"Sleep apnea and the risk of dementia: a systematic review and meta-analysis","volume":"31","author":"Guay-Gagnon","year":"2022","journal-title":"J Sleep Res"},{"issue":"9","key":"10.1016\/j.jsmc.2025.05.002_bib27","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1007\/s00415-022-11120-z","article-title":"REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson\u2019s disease: a cross-sectional and longitudinal study","volume":"269","author":"Nabizadeh","year":"2022","journal-title":"J Neurol"},{"issue":"4","key":"10.1016\/j.jsmc.2025.05.002_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10286-022-00882-1","article-title":"Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review","volume":"32","author":"Singer","year":"2022","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad198","article-title":"Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder","volume":"47","author":"Fernandes","year":"2024","journal-title":"Sleep"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.002_bib30","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","article-title":"Assessment of heterogeneity among participants in the Parkinson\u2019s Progression markers initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study","volume":"22","author":"Siderowf","year":"2023","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.002_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11910-019-0918-y","article-title":"CSF biomarkers for early diagnosis of synucleinopathies: focus on idiopathic RBD","volume":"19","author":"Liguori","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9","key":"10.1016\/j.jsmc.2025.05.002_bib32","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/mds.27806","article-title":"Longitudinal analyses of cerebrospinal fluid \u03b1-Synuclein in prodromal and early Parkinson\u2019s disease","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.jsmc.2025.05.002_bib33","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1007\/s00415-021-10812-2","article-title":"Associations of sleep disorders with cerebrospinal fluid \u03b1-synuclein in prodromal and early Parkinson\u2019s disease","volume":"269","author":"Wang","year":"2022","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.jsmc.2025.05.002_bib34","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/mds.29583","article-title":"Erythrocytic \u03b1-Synuclein species as biomarkers for isolated rapid eye movement sleep behavior disorder","volume":"38","author":"Zheng","year":"2023","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.jsmc.2025.05.002_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-017-1684-z","article-title":"Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson\u2019s disease","volume":"133","author":"Doppler","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.jsmc.2025.05.002_bib36","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/brain\/awab005","article-title":"Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder","volume":"144","author":"Stefani","year":"2021","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.jsmc.2025.05.002_bib37","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/mds.29828","article-title":"Detection of \u03b1-Synuclein in oral mucosa by seed amplification assay in synucleinopathies and isolated REM sleep behavior disorder","volume":"39","author":"Zheng","year":"2024","journal-title":"Mov Disord"},{"key":"10.1016\/j.jsmc.2025.05.002_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.sleep.2018.08.003","article-title":"Alpha-synuclein aggregates in the parotid gland of idiopathic REM sleep behavior disorder","volume":"52","author":"Fern\u00e1ndez-Arcos","year":"2018","journal-title":"Sleep Med"},{"issue":"11","key":"10.1016\/j.jsmc.2025.05.002_bib39","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1002\/acn3.52200","article-title":"\u03b1-Synuclein species in plasma neuron-derived extracellular vesicles as biomarkers for iRBD","volume":"11","author":"Wang","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"10.1016\/j.jsmc.2025.05.002_bib40","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/mds.29766","article-title":"Detecting misfolded \u03b1-Synuclein in blood years before the diagnosis of Parkinson\u2019s disease","volume":"39","author":"Kluge","year":"2024","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamaneurol.2023.4398","article-title":"Neuronally derived extracellular vesicle \u03b1-Synuclein as a serum biomarker for individuals at risk of developing parkinson disease","volume":"81","author":"Yan","year":"2024","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.jsmc.2025.05.002_bib42","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1111\/ene.15537","article-title":"Different patterns of exosomal \u03b1-synuclein between Parkinson\u2019s disease and probable rapid eye movement sleep behavior disorder","volume":"29","author":"Yan","year":"2022","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.jsmc.2025.05.002_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108839","article-title":"Oligomeric Alpha-Synuclein and STX-1A from neural-derived extracellular vesicles (NDEVs) as possible biomarkers of REM sleep behavior disorder in Parkinson\u2019s disease: a preliminary cohort study","volume":"24","author":"Meloni","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.jsmc.2025.05.002_bib44","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12883-024-03642-y","article-title":"Associations of sleep disorders with serum neurofilament light chain levels in Parkinson\u2019s disease","volume":"24","author":"Qi","year":"2024","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jsmc.2025.05.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2023.137394","article-title":"Association between serum neurofilament light chain levels and sleep disorders in patients with Parkinson\u2019s disease","volume":"812","author":"Li","year":"2023","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.002_bib47","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/jnc.15780","article-title":"The relationship between serum neurofilament light chain and glial fibrillary acidic protein with the REM sleep behavior disorder subtype of Parkinson\u2019s disease","volume":"165","author":"Teng","year":"2023","journal-title":"J Neurochem"},{"issue":"7","key":"10.1016\/j.jsmc.2025.05.002_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glae086","article-title":"Longitudinal evolution and plasma biomarkers for excessive daytime sleepiness in Parkinson\u2019s disease","volume":"79","author":"Lin","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10593-7","article-title":"Restless legs syndrome in parkinson disease: clinical characteristics, abnormal iron metabolism and altered neurotransmitters","volume":"7","author":"Piao","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jsmc.2025.05.002_bib50","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/00207454.2019.1608200","article-title":"Decreased serum ferritin May be associated with increased restless legs syndrome in Parkinson\u2019s disease (PD): a meta-analysis for the diagnosis of RLS in PD patients","volume":"129","author":"Li","year":"2019","journal-title":"Int J Neurosci"},{"issue":"12","key":"10.1016\/j.jsmc.2025.05.002_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279747","article-title":"Decreased cerebrospinal fluid orexin levels not associated with clinical sleep disturbance in Parkinson\u2019s disease: a retrospective study","volume":"17","author":"Ogawa","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jsmc.2025.05.002_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2023.03.011","article-title":"Low serum uric acid levels May be a potential biomarker of poor sleep quality in patients with Parkinson\u2019s disease","volume":"105","author":"Zhou","year":"2023","journal-title":"Sleep Med"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib53","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1038\/s41467-024-48961-3","article-title":"Plasma proteomics identify biomarkers predicting Parkinson\u2019s disease up to 7 years before symptom onset","volume":"15","author":"H\u00e4llqvist","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib54","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12974-022-02481-3","article-title":"Parkinson\u2019s disease peripheral immune biomarker profile: a multicentre, cross-sectional and longitudinal study","volume":"19","author":"Li","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"9","key":"10.1016\/j.jsmc.2025.05.002_bib55","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0000000000001308","article-title":"Parkinson disease with REM sleep behavior disorder: features, \u03b1-synuclein, and inflammation","volume":"84","author":"Hu","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40035-024-00421-0","article-title":"DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson\u2019s disease","volume":"13","author":"Appleton","year":"2024","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.jsmc.2025.05.002_bib57","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.sleep.2020.12.012","article-title":"microRNA signatures in prodromal REM sleep behavior disorder and early Parkinson\u2019s disease as noninvasive biomarkers","volume":"78","author":"Titze-de-Almeida","year":"2021","journal-title":"Sleep Med"},{"issue":"9","key":"10.1016\/j.jsmc.2025.05.002_bib58","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/mds.29515","article-title":"Detection of a Parkinson\u2019s disease-specific MicroRNA signature in nasal and oral swabs","volume":"38","author":"Schlie\u00dfer","year":"2023","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.002_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.29643","article-title":"Impaired mitochondrial respiration in REM-sleep behavior disorder: a biomarker of Parkinson\u2019s disease?","volume":"39","author":"Ongari","year":"2024","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11910-015-0607-4","article-title":"Advances in biomarker research in Parkinson\u2019s disease","volume":"16","author":"Mehta","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jsmc.2025.05.002_bib61","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.irn.2017.05.020","article-title":"Biomarkers of nonmotor symptoms in Parkinson\u2019s disease","volume":"133","author":"Konno","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"10.1016\/j.jsmc.2025.05.002_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad030","article-title":"Rapid eye movement sleep behavior disorder: a narrative review from a technological perspective","volume":"46","author":"Gnarra","year":"2023","journal-title":"Sleep"},{"key":"10.1016\/j.jsmc.2025.05.002_bib63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.smrv.2018.01.006","article-title":"Sleep disorders and parkinson disease; lessons from genetics","volume":"41","author":"Gan-Or","year":"2018","journal-title":"Sleep Med Rev"},{"issue":"2","key":"10.1016\/j.jsmc.2025.05.002_bib64","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1021\/acschemneuro.8b00388","article-title":"From rapid eye movement sleep behavior disorder to Parkinson\u2019s disease: possible predictive markers of conversion","volume":"10","author":"Zhou","year":"2019","journal-title":"ACS Chem Neurosci"},{"issue":"s2","key":"10.1016\/j.jsmc.2025.05.002_bib65","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.3233\/JPD-230348","article-title":"Opportunities and pitfalls of REM sleep behavior disorder and olfactory dysfunction as early markers in Parkinson\u2019s disease","volume":"14","author":"Orso","year":"2024","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"10.1016\/j.jsmc.2025.05.002_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40035-022-00286-1","article-title":"Prodromal Parkinson\u2019s disease: hype or hope for disease-modification trials?","volume":"11","author":"Mahlknecht","year":"2022","journal-title":"Transl Neurodegener"},{"issue":"4","key":"10.1016\/j.jsmc.2025.05.002_bib67","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2021-328062","article-title":"Possible predictors of phenoconversion in isolated REM sleep behaviour disorder: a systematic review and meta-analysis","volume":"93","author":"Wang","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Sleep Medicine Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X25000293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556407X25000293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T01:00:32Z","timestamp":1756947632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556407X25000293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1556407X25000293"],"URL":"https:\/\/doi.org\/10.1016\/j.jsmc.2025.05.002","relation":{},"ISSN":["1556-407X"],"issn-type":[{"type":"print","value":"1556-407X"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Biofluid Biomarkers of Sleep Dysfunction in Parkinson\u2019s Disease","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsmc.2025.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}